Literature DB >> 18585921

Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17.

Daisuke Ito1, Taishi Fujisawa, Hiroshi Iida, Norihiro Suzuki.   

Abstract

Seipin, which is encoded by the BSCL2 gene, is a glycoprotein of unknown biochemical function that is associated with dominant hereditary motor neuron diseases. Mutations in the N-glycosylation site of seipin are associated with the disease states and result in accumulation of unfolded protein in the endoplasmic reticulum (ER), leading to the unfolded protein response (UPR) and cell death, suggesting that these diseases are tightly associated with ER stress. Here, we determined the subcellular localization, functional domains, and distribution of seipin in tissues. Our studies show that the transmembrane domains in seipin are critical for ER retention, ubiquitination, formation of inclusions, and activation of UPR. Using immunohistochemistry, seipin expression is detected in neurons in the spinal cord and in the frontal lobe cortex of the brain. The present study provides new insights into the biology of seipin protein that should help our understanding of the pathogenesis of seipin-related diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585921     DOI: 10.1016/j.nbd.2008.05.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  36 in total

1.  Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis.

Authors:  Weihua Fei; Hui Li; Guanghou Shui; Tamar S Kapterian; Christopher Bielby; Ximing Du; Andrew J Brown; Peng Li; Markus R Wenk; Pingsheng Liu; Hongyuan Yang
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

2.  A Patient with Congenital Generalized Lipodystrophy Due To a Novel Mutation in BSCL2: Indications for Secondary Mitochondrial Dysfunction.

Authors:  Ellen H Jeninga; Monique de Vroede; Nicole Hamers; Johannes M P J Breur; Nanda M Verhoeven-Duif; Ruud Berger; Eric Kalkhoven
Journal:  JIMD Rep       Date:  2011-11-04

3.  Seipin mutation at glycosylation sites activates autophagy in transfected cells via abnormal large lipid droplets generation.

Authors:  Hua-dong Fan; Shao-peng Chen; Yu-xiang Sun; Shao-hai Xu; Li-jun Wu
Journal:  Acta Pharmacol Sin       Date:  2015-03-23       Impact factor: 6.150

Review 4.  Seipin: from human disease to molecular mechanism.

Authors:  Bethany R Cartwright; Joel M Goodman
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

5.  Segregated responses of mammary gland development and vaginal opening to prepubertal genistein exposure in Bscl2(-/-) female mice with lipodystrophy.

Authors:  Rong Li; Ahmed E El Zowalaty; Weiqin Chen; Elizabeth A Dudley; Xiaoqin Ye
Journal:  Reprod Toxicol       Date:  2014-11-05       Impact factor: 3.143

6.  Lack of testicular seipin causes teratozoospermia syndrome in men.

Authors:  Min Jiang; Mingming Gao; Chaoming Wu; Hui He; Xuejiang Guo; Zuomin Zhou; Hongyuan Yang; Xinhua Xiao; George Liu; Jiahao Sha
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

7.  Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.

Authors:  Yoshinori Nishimoto; Daisuke Ito; Takuya Yagi; Yoshihiro Nihei; Yoshiko Tsunoda; Norihiro Suzuki
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

Review 8.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

9.  Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation.

Authors:  Rabia Chaudhry; Aditi Kidambi; Megan Hwa Brewer; Anthony Antonellis; Katherine Mathews; Garth Nicholson; Marina Kennerson
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

10.  Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients.

Authors:  Cong Lu; Li-Xi Li; Hai-Lin Dong; Qiao Wei; Zhi-Jun Liu; Wang Ni; Aaron D Gitler; Zhi-Ying Wu
Journal:  J Mol Med (Berl)       Date:  2018-06-11       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.